lovastatin has been researched along with Metabolic Syndrome in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hao, L; Hao, S; Sun, H; Wang, Z; Yu, P; Zhang, M; Zhang, X | 1 |
| Di Giacomo, E; Lenti, S; Manunta, R; Mazza, A; Rubello, D; Schiavon, L; Tomasi, M; Torin, G; Townsend, DM | 1 |
| Ballard, SL; Schoenle, MK | 1 |
| Battista, F; Bonaduce, D; Bosso, G; Brambilla, N; D'Amato, M; Fazio, V; Galletti, F; Gentile, M; Giacovelli, G; Mercurio, V; Pucci, G; Schillaci, G; Vitalini, C | 1 |
| Barbagallo, C; Cicero, AF; Derosa, G; Pisciotta, L | 1 |
| Carlomagno, G; Fazio, S; Mercurio, V; Pirozzi, C; Ruvolo, A | 1 |
| Boden, WE | 1 |
| Ridker, PM | 1 |
| Dement'ev, VI; Gromnatskiĭ, NI; Medvedev, IN; Osipova, VM; Storozhenko, MV; Volobuev, IV | 1 |
| Al-Shaer, MH | 1 |
| Clearfield, M; Downs, JR; Gotto, AM; Langendorfer, A; Lee, M; McConathy, W | 1 |
| Gromnatskiĭ, NI; Medvedev, IN; Osipova, VM; Storozhenko, MV; Volobuev, IV | 1 |
2 review(s) available for lovastatin and Metabolic Syndrome
| Article | Year |
|---|---|
Therapeutic implications of recent ATP III guidelines and the important role of combination therapy in total dyslipidemia management.
Topics: Bezafibrate; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Diabetic Angiopathies; Drug Therapy, Combination; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Lovastatin; Metabolic Syndrome; Practice Guidelines as Topic | 2003 |
Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial.
Topics: Aged; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, LDL; Double-Blind Method; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Metabolic Syndrome; Middle Aged; Multicenter Studies as Topic; Pyrimidines; Randomized Controlled Trials as Topic; Research Design; Risk Factors; Rosuvastatin Calcium; Sulfonamides | 2003 |
5 trial(s) available for lovastatin and Metabolic Syndrome
| Article | Year |
|---|---|
Effect of Monacolin K and COQ10 supplementation in hypertensive and hypercholesterolemic subjects with metabolic syndrome.
Topics: Aged; Anticholesteremic Agents; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Diet, Mediterranean; Dietary Supplements; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Lovastatin; Male; Metabolic Syndrome; Middle Aged; Treatment Outcome; Triglycerides; Ubiquinone | 2018 |
Efficacy of a nutraceutical combination on lipid metabolism in patients with metabolic syndrome: a multicenter, double blind, randomized, placebo controlled trial.
Topics: Adult; Aged; Berberine; Cholesterol, LDL; Dietary Supplements; Double-Blind Method; Fatty Alcohols; Female; Humans; Hypertrophy, Left Ventricular; Insulin Resistance; Lipid Metabolism; Lovastatin; Male; Metabolic Syndrome; Middle Aged; Placebos; Treatment Outcome | 2019 |
Testing the Short-Term Efficacy of a Lipid-Lowering Nutraceutical in the Setting of Clinical Practice: A Multicenter Study.
Topics: Adult; Anticholesteremic Agents; Biological Products; Cholesterol; Cholesterol, LDL; Dietary Supplements; Fatty Acids, Unsaturated; Female; Humans; Hypercholesterolemia; Lipids; Lovastatin; Male; Metabolic Syndrome; Middle Aged; Phytosterols; Treatment Outcome; Triglycerides | 2015 |
Effects of a nutraceutical combination on left ventricular remodeling and vasoreactivity in subjects with the metabolic syndrome.
Topics: Anticholesteremic Agents; Berberine; Cardiotonic Agents; Dietary Supplements; Fatty Alcohols; Female; Humans; Insulin Resistance; Lovastatin; Male; Metabolic Syndrome; Middle Aged; Vasodilation; Ventricular Remodeling | 2012 |
Implications from the Air Force/Texas Coronary Atherosclerosis Prevention Study for the Adult Treatment Panel III guidelines.
Topics: Aged; Anticholesteremic Agents; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Double-Blind Method; Female; Follow-Up Studies; Humans; Lovastatin; Male; Metabolic Syndrome; Middle Aged; Military Personnel; Practice Guidelines as Topic; Retrospective Studies; Risk Factors; Treatment Outcome | 2005 |
5 other study(ies) available for lovastatin and Metabolic Syndrome
| Article | Year |
|---|---|
Synthesis of natural 3'-Prenylchalconaringenin and biological evaluation of ameliorating non-alcoholic fatty liver disease and metabolic syndrome.
Topics: 3T3-L1 Cells; AMP-Activated Protein Kinases; Animals; Chalcones; Chemistry Techniques, Synthetic; Hep G2 Cells; Humans; Metabolic Syndrome; Mice; Non-alcoholic Fatty Liver Disease; Signal Transduction; Stereoisomerism | 2020 |
Response to "Effect of monacolin K and COQ10 supplementation in hypertensive and hypercholesterolemic subjects with metabolic syndrome".
Topics: Dietary Supplements; Humans; Lovastatin; Metabolic Syndrome; Ubiquinone | 2019 |
[Thrombocytic hemostasis in hypertensive patients with metabolic syndrome and its correction with lovastatin].
Topics: Anticholesteremic Agents; Data Interpretation, Statistical; Exercise; Female; Humans; Hypertension; Lipid Peroxidation; Lovastatin; Male; Metabolic Syndrome; Middle Aged; Time Factors | 2004 |
Is atorvastatin more appropriate to use in combination with niacin than simvastatin in patients with the metabolic syndrome?
Topics: Drug Combinations; Humans; Lovastatin; Metabolic Syndrome; Niacin; Uric Acid | 2005 |
[Correction of thrombocyte-vascular hemostasis in metabolic syndrome].
Topics: Adult; Anticholesteremic Agents; Blood Platelets; Female; Hemostasis; Humans; Hypertension; Lovastatin; Male; Metabolic Syndrome; Middle Aged | 2006 |